These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22032752)

  • 1. Number needed to screen--how can we project outside context?
    Auvinen A
    J Clin Epidemiol; 2011 Dec; 64(12):1275-6. PubMed ID: 22032752
    [No Abstract]   [Full Text] [Related]  

  • 2. Early-stage prostate cancer, PSA screening rates decline.
    Printz C
    Cancer; 2016 Mar; 122(6):825. PubMed ID: 26938268
    [No Abstract]   [Full Text] [Related]  

  • 3. Why I will continue to screen prostate-specific antigen for myself and other appropriate men.
    Keller DL
    JAMA Intern Med; 2014 Jan; 174(1):164. PubMed ID: 24394929
    [No Abstract]   [Full Text] [Related]  

  • 4. Why I will continue to screen prostate-specific antigen for myself and other appropriate men--reply.
    Katz MH
    JAMA Intern Med; 2014 Jan; 174(1):164. PubMed ID: 24394931
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostate-specific antigen, risk factors, and prostate cancer: confounders nestled in an enigma.
    Thompson IM; Ankerst DP; Tangen CM
    J Natl Cancer Inst; 2010 Sep; 102(17):1299-301. PubMed ID: 20724727
    [No Abstract]   [Full Text] [Related]  

  • 6. Reconsidering Prostate Cancer Screening.
    Schmidt C
    J Natl Cancer Inst; 2017 Jan; 109(1):1-2. PubMed ID: 28104781
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostate-specific antigen testing in france.
    Braillon A
    JAMA Intern Med; 2013 Nov; 173(21):2014. PubMed ID: 24276059
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostate-specific antigen as a tumor marker in prostate cancer.
    Kuriyama M
    Int J Urol; 1994 Jun; 1(2):99-113. PubMed ID: 7543013
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prostate cancer screening: no proof of the benefit].
    Laplanche A; Hill C
    Presse Med; 2009 Oct; 38(10):1393-5. PubMed ID: 19647979
    [No Abstract]   [Full Text] [Related]  

  • 10. [You have to take the prostate cancer seriously].
    Stief CG
    MMW Fortschr Med; 2012 Jan; 154(1):42. PubMed ID: 22642002
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostate-specific antigen: does the current evidence support its use in prostate cancer screening?
    Duffy MJ
    Ann Clin Biochem; 2011 Jul; 48(Pt 4):310-6. PubMed ID: 21525152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: mortality results after 13 years of follow-up.
    Braillon A; Dubois G
    J Natl Cancer Inst; 2012 May; 104(10):793; author reply 793-4. PubMed ID: 22491229
    [No Abstract]   [Full Text] [Related]  

  • 13. Patients Present with More Advanced Prostate Cancer since the USPSTF Screening Recommendations.
    Barry MJ; Nelson JB
    J Urol; 2015 Dec; 194(6):1534-6. PubMed ID: 26384450
    [No Abstract]   [Full Text] [Related]  

  • 14. Our shifting understanding of factors influencing prostate-specific antigen.
    Singer EA; DiPaola RS
    J Natl Cancer Inst; 2013 Sep; 105(17):1264-5. PubMed ID: 23943863
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current results on PSA-based prostate cancer detection].
    Graefen M; Schlomm T; Steuber T; Sauter G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Mar; 57(3):312-7. PubMed ID: 24562706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for Prostate Cancer-Beyond Total PSA, Utilization of Novel Biomarkers.
    Morgan T; Palapattu G; Wei J
    Curr Urol Rep; 2015 Sep; 16(9):63. PubMed ID: 26169584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Numbers needed to decide.
    Woloshin S; Schwartz LM
    J Natl Cancer Inst; 2009 Sep; 101(17):1163-5. PubMed ID: 19671771
    [No Abstract]   [Full Text] [Related]  

  • 18. Further evidence that prostate-specific antigen screening reduces prostate cancer mortality.
    Stampfer MJ; Jahn JL; Gann PH
    J Natl Cancer Inst; 2014 Mar; 106(3):dju026. PubMed ID: 24610908
    [No Abstract]   [Full Text] [Related]  

  • 19. A rational basis for chemoprevention of prostate cancer.
    Huang CJ; Baum ML
    Am J Bioeth; 2011 Dec; 11(12):27-9. PubMed ID: 22146027
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: an empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection.
    Loeb S; Metter EJ; Carter HB
    J Natl Cancer Inst; 2011 Nov; 103(21):1636-7; author reply 1637. PubMed ID: 21926375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.